Skyscape Web Viewer : The Washington Manual of Medical Therapeutics : Main Index

View All
Delirium Alterations in Consciousness Tetanus
Dengue
Denosumab
Dense deposit disease (DDD)
Department of Health and Human Services
Deposition disorders
Depression headache transgender patients
Dermatomyositis (DM) Idiopathic Inflammatory Myopathies Other Neuromuscular Disorders
Desmopressin (DDAVP) for hemophilia A for uremic platelet dysfunction for von Willebrand disease
Desquamative interstitial pneumonia (DIP)
Dexamethasone Acute Spinal Cord Dysfunction for coma for COVID-19 for meningitis tuberculosis
Multidose charcoal
Multidrug anti-TB treatment regimens
Multidrug-resistant tuberculosis
Multifocal atrial tachycardia (MAT)
Multiple myeloma (MM)
Multiple sclerosis (MS)
Musculoskeletal involvement diffuse scleroderma polyarteritis nodosa (PAN)
MuSK antibodies
Myasthenia gravis (MG)
Myasthenic crisis
Mycobacterium avium complex (MAC) infection
Mycobacterium leprae
Mycobacterium tuberculosis Mycobacterium Tuberculosis Tuberculosis
Mycophenolate mofetil for systemic lupus erythematosus (SLE) lupus nephritis (LN) polymyositis (PM) Synthetic Dmards
Mycophenolic acid (MPA)
Mycoses
Myelodysplastic syndromes (MDS) Myelodysplastic Syndrome Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes
Myeloproliferative neoplasms
Myeloproliferative variants